Dr. Stamatios Lerakis, MD

Dr. Lerakis practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Lerakis' NPI, 1043227895, was assigned on August 2, 2006. Dr. Lerakis holds New York license 196600.

Dr. Lerakis' primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Lerakis also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Lerakis' primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Lerakis is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Lerakis to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lerakis practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lerakis' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Lerakis' licenses on file in 2 states: New York and Georgia.

CMS data shows 5,616 Medicare services from Dr. Lerakis across 14 procedure codes in 2024, for 2,504 Medicare patients. Medicare paid $211,165 for them.

CMS counts 2,504 Medicare patients who saw Dr. Lerakis in 2024. The largest group is 75 to 84, with 945 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lerakis' median patient age at 66, with 45% women.

In 2018, Dr. Lerakis wrote 279 Medicare Part D claims. They cover 12 drugs, with $5,574 in total drug cost. In 2017, CMS named 361 claims across 13 drugs.

Dr. Lerakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 346 papers to Dr. Lerakis, published from 2006 to 2025. 2021 was the busiest year, with 26. The most frequent topics are Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement and Heart Valve Prosthesis. Dr. Lerakis has published most often in JACC Cardiovasc Interv. Dr. Lerakis' most frequent co-authors are Vasilis C. Babaliaros, MD, Annapoorna S. Kini, MD and Samin Sharma, MD.

Dmand AI links Dr. Lerakis to 1 clinical trial. Conditions studied include Mitral Valve Insufficiency and Heart Valve Diseases.

CMS Open Payments shows 166 general payments to Dr. Lerakis from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 29% of the total. Abbott Laboratories paid the most, $18,729.

Dmand AI lists 1 award for Dr. Lerakis.

Dr. Lerakis is in network with 20 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.